Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Jorgensen became CEO in January 2017 and the company’s market capitalization has more than tripled during his tenure. Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, but ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Novo Nordisk rode Ozempic's success to becoming Europe's top company. Now it's faltering and its CEO is out. Novo Nordisk rode Ozempic's success to becoming Europe's top company. Now it's faltering ...

Throughout the country, homeowners are assessing how they can afford the rising cost of insurance, especially if they live in ...

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.

Many Wall Street analysts think Novo Nordisk will make a solid rebound over the next 12 months. The company may have ...

The president’s Middle East visit produced multibillion-dollar technology investments by the Saudis and Emiratis. But they ...

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...

A generally good week closes on another positive note, as investors, traders and speculators look for fresh catalysts.